ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
25/09/2024
Voltar para busca
Dado oficial do USPTO
C
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
72
Atualização mais recente
25/09/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 10, 42, 44
Data de depósito
21/06/2007
Data de registro
21/09/2010
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/10/2019
Última transação
17/09/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
16
Localização do titular
MANNHEIM, DE
Examinador
FLETCHER, TRACY
Unidade examinadora
M60
Localização atual
GENERIC WEB UPDATE
Descrição da marca
The mark consists of a stylized letter "C" with a vertical line passing through it, with the letter "C" being blurred to the left of the line and clear or in focus to the right of the vertical line.
Titulares e representantes
Titulares
ROCHE DIAGNOSTICS GMBH
ROCHE MTM LABORATORIES AG
MTM Laboratories AG
Representantes
Mona Gupta Roche Diagnostics Operations, Inc.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industry and sciencediagnostic preparationsreagents and chemical test kits comprised of reagents for chemical analyses and reagents for medical research use for detection of cancerous conditionsneoplastic conditionsinflammatory conditionsinfectious conditionsdegenerative conditionsgenetically aberrant or diseased conditionsproliferatively aberrant or diseased conditionsvascular disease conditionspremalignant conditionsmalignant conditionscancer and inborn errors for scientific or research use
Classe 5
Pharmaceutical and veterinary preparationspharmaceutical preparations for the treatment and prevention of neoplasticinflammatoryinfectiousdegenerativegeneticproliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditionscancer and inborn errors; veterinary preparations for the treatment and prevention of neoplasticinflammatoryinfectiousdegenerativegenetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditionscancer and inborn errors in livestockcattlepigshorsesdeerelkmoosesheepdogscatsmiceratsmonkeysapes and birds; medical diagnostic reagents and kits comprised of medical diagnostic reagents and assays for detection of cancer and neoplasticinflammatoryinfectiousdegenerativegeneticproliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditionscancer and inborn errors; medical diagnostic preparationsin-vitro and in-vivo diagnostic test kitsdiagnostic immunocytochemical kitsdiagnostic immunohistochemical kitsdiagnostic histology kitsdiagnostic cytology kitsdiagnostic liquid-immuno-assay kitsdiagnostic solid-phase immuno-assay kitsdiagnostic strip-testsdiagnostic dip-stick-testspoint of care testsdiagnostic lateral-flow assay kitsdiagnostic flow-through assay kitsdiagnostic immuno-chromatographic kitsall of the above-mentioned kits being for use in early diagnosisprognosisgradingmonitoringstagingpredictive therapy guidancepatient stratification or therapy guidance of premalignant and malignant conditionscancerinborn errors and infectiousgeneticproliferative or vascular diseases; medical diagnostic test strips and diagnostic dip-stick tests for use in early diagnosisprognosisgradingmonitoringstagingpredictive therapy guidancepatient stratification or therapy guidance of premalignant and malignant conditionscancerinborn errors and infectiousgeneticproliferative or vascular diseases
Classe 10
Diagnostic testing machinespoint-of-care testing machinesdiagnostic liquid-immuno-assay machinesdiagnostic immunocytochemical machinesdiagnostic immunohistochemical machinesdiagnostic histology machinesdiagnostic cytology machinesdiagnostic solid-phase immuno assay machinesdiagnostic ELISA testing machinesdiagnostic immuno-chromatographic machinesall of the aforementioned machines being used to analyze and/or provide diagnostic test results and used in connection with early diagnosisprognosisgradingmonitoringstagingpredictive therapy guidancepatient stratification or therapy guidance of premalignant and malignant conditionscancerinborn errors and infectious and genetic diseases associated with cancerproliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; medical diagnostic equipmentcontainers specially designed for storing and transporting medical samples in the nature of tubesmultiwell platescolumnsstripssticksbrushesall for sampling of medical samples from body cavities and epithelia; medical syringesneedles for medical usespatulas for medical samples and medical diagnostic testingmedical diagnostic testing swabsclothstamponsall for use in samplingstoringtransportingpreparingenrichingconcentratingtestinganalyzing and evaluating biological material and samples in connection with early diagnosisprognosisgradingmonitoringstagingpredictive therapy guidancepatient stratification and therapy guidance of premalignant and malignant conditionscancerinborn errors and infectiousgeneticproliferative and vascular diseases as indicated above; diagnostic nucleic acid detection machinesdiagnostic nucleic acid amplification machinesdiagnostic immuno-histology machines and diagnostic immuno-cytology machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosisprognosisgradingmonitoringstagingpredictive therapy guidancepatient stratification or therapy guidance of premalignant and malignant conditionscancerinborn errors and infectious and genetic diseases associated with cancerproliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; medical diagnostic apparatuses and instrumentshand-heldtable-top and floor-standing centrifugalgravitational-separatingelectrophoreticchromatographicconductometricpotentiometricspectrometricspectro-photometricradiologic electromagnetic-resonancehistologicalmicroscopic and in-vivo-imaging machines and apparatuses for use in preparingenrichingconcentratingtestinganalyzing and evaluating of biological material and samples in connection with early diagnosisprognosisgradingmonitoringstagingpredictive therapy guidancepatient stratification and therapy guidance of premalignant and malignant conditionscancerinborn errors and infectiousgeneticproliferative and vascular diseases as indicated above for clinical and medical laboratory use
Classe 42
Scientific and technological services and research and design relating theretoindustrial analysis and research servicesdesign and development of computer hardware and softwarescientific analysis in the fields of chemistrybiology and molecular biologylaboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing research in the fields of pharmaceuticalchemical and diagnostic research; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemicalbiologicalmolecular biology and pharmacogenomic analysis services
Classe 44
Medical servicesveterinary servicesmedical diagnostic services and provision of medical diagnostic information in the field of detection of neoplasticinflammatoryinfectiousdegenerativegeneticproliferative and vascular diseasespremalignant and malignant cancerous conditionscancer and inborn errors; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplasticinflammatoryinfectiousdegenerativegeneticproliferative and vascular diseasespremalignant and malignant cancerous conditionscancer and inborn errors in livestockcattlepigshorsesdeerelkmoosesheepdogscatsmiceratsmonkeysapes and birds
Publicações
Histórico de despachos e eventos da marca no USPTO.
72 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/09/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
13/09/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
13/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/09/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/10/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/10/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/10/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/10/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/10/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/10/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/10/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/10/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/10/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/10/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/10/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/10/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/12/2019
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/10/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/10/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/10/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
02/10/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/10/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/10/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
21/09/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/01/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/01/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/05/2017
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/05/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/05/2017
E815
TEAS SECTION 8 & 15 RECEIVED
20/03/2017
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
24/03/2014
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
24/03/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/04/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/04/2012
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
18/04/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
21/09/2010
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
14/08/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/08/2010
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/08/2010
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
09/08/2010
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
09/02/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/11/2009
PUBO
PUBLISHED FOR OPPOSITION
17/11/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/10/2009
ALIE
ASSIGNED TO LIE
07/10/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/10/2009
DMCC
DATA MODIFICATION COMPLETED
06/10/2009
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/10/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/10/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/09/2009
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
30/09/2009
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
31/03/2009
GNSI
INQUIRY TO SUSPENSION E-MAILED
31/03/2009
CNSI
SUSPENSION INQUIRY WRITTEN
31/03/2009
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
31/03/2009
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
29/09/2008
GNSL
LETTER OF SUSPENSION E-MAILED
29/09/2008
CNSL
SUSPENSION LETTER WRITTEN
29/09/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/05/2008
ALIE
ASSIGNED TO LIE
06/05/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/05/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/05/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/11/2007
GNRT
NON-FINAL ACTION E-MAILED
04/11/2007
CNRT
NON-FINAL ACTION WRITTEN
04/11/2007
DOCK
ASSIGNED TO EXAMINER
24/09/2007
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
26/06/2007
NWAP
NEW APPLICATION ENTERED
25/06/2007
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace C ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.